Vantage Markets to Participate in iFX Expo LATAM 2025
PORT VILA, Vanuatu, March 20, 2025 /PRNewswire/ — Vantage Markets announces its participation in iFX Expo LATAM 2025, a leading financial B2B expo, set to... Read more.
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events
New capabilities within Oracle Cloud HCM enable HR teams, managers, and employees to drive engagement, increase productivity, and enhance company culture LONDON,... Read more.
Oracle Introduces AI Agent Studio
New Oracle AI Agent Studio empowers Oracle Fusion Cloud Applications customers and partners to easily create, extend, deploy, and manage AI agents and agent teams... Read more.
Oracle and Microsoft Add Powerful, Flexible New Services to Oracle Database@Azure and Expand Regional Availability
Oracle Exadata Database Service on Exascale Infrastructure now available Oracle Base Database Service on Oracle Database@Azure is coming soon AUSTIN, Texas, March... Read more.
ION releases RightAngle S25 for navigating the evolving liquid hydrocarbon market
LONDON, March 20, 2025 /PRNewswire/ — ION Commodities, a leading global provider of energy and commodity management solutions, has released the latest version... Read more.
Four Nigerian Governors, Nnamdi Ekeh to Receive FIN-Forbes Awards at 2025 Renewable Energy Roundtable in Dubai
LAGOS, Nigeria, March 20, 2025 /PRNewswire/ — The Foreign Investment Network (FIN) is set to host its highly anticipated 2025 Annual FIN-Forbes Renewable Energy... Read more.
Qudian Inc. Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results
XIAMEN, China, March 20, 2025 /PRNewswire/ — Qudian Inc. (“Qudian” or “the Company” or “We”) (NYSE: QD), a consumer-oriented... Read more.
AEGEAN Prioritizes Passenger Experience and Builds Loyalty with Oracle
The Greek flag carrier taps Oracle Fusion Cloud Customer Experience (CX) to personalize traveler experiences, boost revenue, and increase customer loyalty LONDON,... Read more.
Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic
Visionary sector leaders Dan Menichella and Jo Brewer, PhD join as Non-Executive Directors Bringing strengths in strategy, immuno-oncology science execution from... Read more.
Versameb AG Announces Grant of First Patent in China for “Signal Peptide with Heterologous Protein”
BASEL, Switzerland, March 20, 2025 /PRNewswire/ — Versameb AG (“Versameb“), a clinical stage company focused on transforming RNA therapeutics to... Read more.